{
  "id": 19921431,
  "title": "Molina Healthcare chief legal officer sells $1.62M in shares",
  "url": "https://urgent.news/2026/11/14/molina-healthcare-chief-legal-officer-sells-1-62m-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-14T04:15:59.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/molina-healthcare-chief-legal-officer-sells-162m-in-shares-93CH-5027045"
  },
  "original_language": "en",
  "account": "Jeff D. Barlow, the chief legal officer at Molina Healthcare, recently sold a significant portion of the company's shares. On November 10, 2026, Mr. Barlow transferred 8,000 shares of Molina Healthcare's common stock, totaling $1.62 million. The shares were sold within a narrow price range of $203.01 to $203.07. The stock has seen a 52% return over the past year and is currently trading at $209.49. Analysts consider the stock to be undervalued, with price targets ranging from $163 to $266. Following the sale, Barlow personally holds 59,313 shares of Molina Healthcare common stock, with future vesting scheduled over the next three years. Meanwhile, Molina Healthcare's third-quarter 2026 results exceeded Wall Street expectations, with adjusted earnings of $0.89 per share and revenue of $11.08 billion. Despite this strong performance, the company has not increased its full-year guidance. Analysts from Bernstein and Mizuho have maintained their \"Outperform\" ratings, with price targets of $266.00 and $255.00, respectively. Jefferies raised its price target to $220 and assigned a \"Hold\" rating, while Cantor Fitzgerald kept a \"Neutral\" rating with a $209.00 target. These developments highlight the company's strong earnings performance but also caution about potential revenue and cost pressures.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}